purpose present results uveal melanomas treated medicyc cyclotron NUMBER mev proton beam facility nice analyzing factors affect survival css metastatic rate reporting visual outcome methods materials study concerns NUMBER patients referred french institutions june NUMBER december NUMBER eye tumor parameters measured using ultrasonography angiography NUMBER ct scans performed patients help determine axial length shape ocular globe tantalum clips inserted tumor referring ophthalmologist NUMBER posterior pole tumors NUMBER NUMBER equatorial tumors NUMBER NUMBER ciliary body tumors NUMBER patients NUMBER t1 t2 tumors NUMBER patients NUMBER t3 t4 tumors median tumor diameter NUMBER mm median tumor height NUMBER mm patients received NUMBER gy NUMBER gy dose NUMBER consecutive days data analyzed december NUMBER results css NUMBER NUMBER months overall survival NUMBER local control NUMBER css influenced patient age site tumor NUMBER t1 t2 tumors versus NUMBER t3 t4 tumors p NUMBER tumor diameter height important parameter affecting outcome metastatic rate NUMBER depended t stage tumor diameter thickness tumor site enucleations performed tumor progression glaucoma patients visual acuity adequately scored treatment stable improved vision half patients retained useful vision treatment conclusion outcome patients suffering uveal melanoma treated protons compares favorably techniques treatment tumor dimensions affected css metastatic rate patients posterior pole tumors half retained useful vision cause specific equivalent thirty high energy thirds